Purdue Sues Ranbaxy Again Over Generic OxyContin
Purdue Pharma LP accused Ranbaxy Pharmaceuticals Inc. of infringing three of its patents for OxyContin in a lawsuit made public Tuesday, marking Purdue's latest challenge to the generics maker's attempt to...To view the full article, register now.
Already a subscriber? Click here to view full article